Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Status: | Recruiting |
---|---|
Conditions: | Ovarian Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/10/2018 |
Start Date: | January 2016 |
Contact: | Ashley Haggerty, MD |
Email: | PennCancerTrials@emergingmed.com |
Phone: | 855-216-0098 |
The primary objective is to administer a cross-sectional survey to directly compare the
differences patients and physicians hold regarding ovarian cancer prognosis and survival,
complications arising from treatment, and counseling on advance directives, living wills,
palliative care, and hospice services. Overall, the project will pinpoint opportunities for
better patient physician communication regarding prognosis and end-of-life care and allow for
more informed and tailored decision-making.
differences patients and physicians hold regarding ovarian cancer prognosis and survival,
complications arising from treatment, and counseling on advance directives, living wills,
palliative care, and hospice services. Overall, the project will pinpoint opportunities for
better patient physician communication regarding prognosis and end-of-life care and allow for
more informed and tailored decision-making.
Inclusion Criteria:
- women over 18 years old with biopsy-confirmed malignancy
- being actively treated or are in surveillance for epithelial ovarian cancer
- have an existing therapeutic relationship with a provider who is participating in the
study.
Exclusion Criteria:
- patients enrolled in palliative or hospice care programs, patients with a second
primary malignancy within the last five years (excluding non-melanoma skin cancer)
- patients who are illiterate or non-English speaking, and patients without
decision-making capacity.
- There are no exclusion criteria based on age, gender, economic status or
race/ethnicity
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Ashley Haggerty, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials